Compounds > kelatorphan
Page last updated: 2024-09-03

kelatorphan and deltakephalin

kelatorphan has been researched along with deltakephalin in 5 studies

Compound Research Comparison

Studies
(kelatorphan)		Trials
(kelatorphan)		Recent Studies (post-2010)
(kelatorphan)		Studies
(deltakephalin)		Trials
(deltakephalin)		Recent Studies (post-2010) (deltakephalin)
58017900

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benoliel, JJ; Berthier, JL; Bourgoin, S; Cesselin, F; Hamon, M; Hirsch, M; Mauborgne, A1
Daugé, V; Roques, BP; Rossignol, P2
de Witte, P; Heidbreder, C; Roques, BP1
Fournie-Zaluski, MC; Glowinski, J; Hamon, M; Petit, F; Roques, BP1

Other Studies

5 other study(ies) available for kelatorphan and deltakephalin

ArticleYear
Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:2

    Topics: Animals; Captopril; Dipeptides; In Vitro Techniques; Leucine; Male; Metalloendopeptidases; Naloxone; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Potassium; Protease Inhibitors; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Thiorphan; Tiopronin

1987
Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Psychopharmacology, 1989, Volume: 99, Issue:2

    Topics: Animals; Apomorphine; Behavior, Animal; Caudate Nucleus; Dipeptides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Microinjections; Motor Activity; Nucleus Accumbens; Oligopeptides; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Septal Nuclei

1989
Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    Neuropharmacology, 1989, Volume: 28, Issue:7

    Topics: Animals; Behavior, Animal; Dextroamphetamine; Dipeptides; Electrodes, Implanted; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Injections; Injections, Intraventricular; Male; Neprilysin; Nucleus Accumbens; Oligopeptides; Rats; Rats, Inbred Strains; Self Stimulation

1989
Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
    Psychopharmacology, 1988, Volume: 96, Issue:3

    Topics: Animals; Behavior, Animal; Caudate Nucleus; Dipeptides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Motor Activity; Naloxone; Neprilysin; Norepinephrine; Nucleus Accumbens; Oligopeptides; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu

1988
Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release.
    European journal of pharmacology, 1986, Jul-15, Volume: 126, Issue:1-2

    Topics: Animals; Corpus Striatum; Dipeptides; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; In Vitro Techniques; Male; Nucleus Accumbens; Oligopeptides; Potassium; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Synapses

1986